Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes
10.1002/jgh3.12850
Saved in:
Main Authors: | Tan, Chee-Kiat, Luo, Xue-Shi, Ong, Benjamin Shao-Kiat, Lin, Liang, Ng, Kwong-Hoe |
---|---|
Other Authors: | DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) |
Format: | Article |
Language: | English |
Published: |
WILEY
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/241706 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection
by: Colvin,R.A., et al.
Published: (2015) -
Comparison of anal dilatation versus no dilatation with a standardized dilator in reducing pain after hemorrhoidectomy: a randomized control trial
by: Sofii, Imam, et al.
Published: (2022) -
Predictor of Liver Biochemistry Improvement in Patients with Cytomegalovirus Cholestasis after Ganciclovir Treatment
by: Puspita, Gina, et al.
Published: (2022) -
National Consensus on Portal Hypertension Management in Indonesia
by: Kurniawan, Juferdy, et al.
Published: (2022) -
A study of 3013 cases of hepatocellular carcinoma: Etiology and therapy before and during the current decade
by: Lim, Miao-Shan, et al.
Published: (2023)